Context Therapeutics Inc
F:6K9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Context Therapeutics Inc
F:6K9
|
US |
|
M
|
Marchex Inc
XMUN:NHM
|
US |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
P
|
Promotora y Operadora de Infraestructura SAB de CV
SWB:AKY
|
MX |
|
A
|
Allstate Corp
XBER:ALS
|
US |
|
Sinopec Oilfield Service Corp
SSE:600871
|
CN |
|
I
|
ITV PLC
F:IJ7
|
UK |
|
H
|
Huntington Ingalls Industries Inc
SWB:HI4
|
US |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
F
|
Fairfax Financial Holdings Ltd
F:FFX
|
CA |
|
Noble Corporation PLC
F:85V1
|
US |
|
S
|
SandRidge Energy Inc
SWB:SA2D
|
US |
|
B
|
Brady Corp
SWB:BRV
|
US |
|
Huatai Securities Co Ltd
OTC:HUATF
|
CN |
|
C
|
Commerzbank AG
XMUN:CBK
|
DE |
|
S
|
Stepan Co
F:96S
|
US |
|
V
|
Vinci SA
XMUN:SQU
|
FR |
|
A
|
Aurubis AG
XMUN:NDA
|
DE |
|
P
|
Phunware Inc
F:2RJ
|
US |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
Mercer International Inc
NASDAQ:MERC
|
CA |
|
Life Healthcare Group Holdings Ltd
OTC:LTGHF
|
ZA |
|
M
|
Molson Coors Beverage Co
DUS:NY7
|
US |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
Wall St Price Targets
6K9 Price Targets Summary
Context Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
6K9 is 3.707 EUR with a low forecast of 2.447 EUR and a high forecast of 5.088 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6K9's stock price target?
Price Target
3.707
EUR
According to Wall Street analysts, the average 1-year price target for
6K9 is 3.707 EUR with a low forecast of 2.447 EUR and a high forecast of 5.088 EUR.